Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director comp.
Director departure

Bioventus Inc. (BVS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 10-Q Quarterly Report for the period ended July 1, 2023
08/08/2023 8-K Quarterly results
Docs: "Bioventus Reports Second Quarter Financial"
06/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/16/2023 SC 13D/A Juniper Investment Company, LLC reports a 10.7% stake in Bioventus, Inc.
06/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BIOVENTUS INC. 2023 RETENTION EQUITY AWARD PLAN",
"BIOVENTUS INC. 2023 RETENTION EQUITY AWARD PLAN"
05/26/2023 8-K Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits  Interact...
Docs: "Bioventus Completes Divestiture of",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION"
05/24/2023 SC 13D/A Juniper Investment Company, LLC reports a 9.5% stake in Bioventus, Inc.
05/16/2023 10-Q Quarterly Report for the period ended April 1, 2023
05/16/2023 8-K Quarterly results
Docs: "Bioventus Reports First Quarter Financial Results"
05/16/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Asset Purchase Agreement, by and among Misonix, LLC, Solsys Medical, LLC, Bioventus LLC and LifeNet Health",
"Bioventus Announces Divestiture of its Wound Business"
05/11/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/11/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Bioventus Reschedules Earnings Call to May 16, 2023 Files for Extension to File Form 10-Q for the Period Ended April 1, 2023"
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/18/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
04/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement and Release between Kenneth Reali and Bioventus Inc."
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/31/2023 8-K Quarterly results
Docs: "Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results"
03/16/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/28/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/14/2023 SC 13G Nantahala Capital Management, LLC reports a 5.1% stake in BIOVENTUS INC.
02/07/2023 SC 13G/A AMP-CF Holdings, LLC reports a 5.2% stake in Bioventus Inc.
01/09/2023 8-K Quarterly results
12/07/2022 8-K Cost Associated with Exit or Disposal Activities  Interactive Data
11/21/2022 8-K/A Quarterly results
Docs: "Bioventus Issues Revised Third Quarter Results&#59; Updates Full-Year 2022 Financial Guidance"
11/21/2022 10-Q Quarterly Report for the period ended October 1, 2022
11/16/2022 8-K Quarterly results
Docs: "Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022"
11/16/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
11/15/2022 SC 13D/A Juniper Investment Company, LLC reports a 7.4% stake in Bioventus, Inc.
11/08/2022 8-K Quarterly results
Docs: "Bioventus Reports Third Quarter Results&#59; Updates Full-Year 2022 Financial Guidance"
09/27/2022 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "CONSENT OF INDEPENDENT ACCOUNTANTS",
"CARTIHEAL LTD. 2021 CONSOLIDATED FINANCIAL STATEMENTS",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION"
08/31/2022 8-K Resignation/termination of a director
08/12/2022 10-Q Quarterly Report for the period ended July 2, 2022
08/11/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy